Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

273 Press Releases
DateTitleCompany
20 Sep 13 Teva Announces Exclusive Launch of Generic NIASPAN® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Aug 13 Teva Reports Top-Line Results from Final Phase III Study of Armodafinil (NUVIGIL®) in Patients with Major Depression Associated with Bipolar I Disorder Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Aug 13 Leading Proxy Advisory Firms Recommend Vote in Favor of All Proposals for Teva Pharmaceutical's Annual Meeting Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
13 Aug 13 Teva to Present at the Canaccord Genuity 33rd Annual Growth Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
16 Jul 13 Teva to Report Second Quarter 2013 Financial Results on August 1, 2013 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
24 Jun 13 Teva Launches Generic Version of Viagra® (sildenafil) in Countries Across Europe Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Jun 13 Teva Strengthens Respiratory Franchise with Acquisition of MicroDose Therapeutx Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Jun 13 Teva to Present at the Goldman Sachs 34th Annual Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Jun 13 Teva Reaches Settlement Agreement with Pfizer and Nycomed Regarding Generic Protonix® (Pantoprazole) Tablets Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 May 13 Teva Announces FDA Acceptance of sNDA for a Higher Concentration Dose of COPAXONE® Given Three Times a Week Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
24 May 13 Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
29 Apr 13 Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Apr 13 Teva Establishes Global Specialty Medicines Group Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Apr 13 Teva Presented New Data from Phase III Clinical Trial of MilprosaÔäó (Progesterone) Vaginal Ring at the 61st Annual Meeting of the Pacific Coast Reproductive Society Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
10 Apr 13 Teva to Report First Quarter 2013 Financial Results on May 2, 2013 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Apr 13 Teva-Handok Names Yoo Suk Hong as Chief Executive Officer Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Apr 13 Teva Names Ichiro Kikushige as CEO of Teva Seiyaku, Japan Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Mar 13 Teva to Present at the 2013 Barclays Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
09 Mar 13 Teva Files 2012 Annual Report on Form 20-F Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Mar 13 Teva Calls 5.550% Senior Notes Due 2016 for Redemption Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Feb 13 Teva to Present at the 2013 RBC Capital Markets Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
22 Feb 13 Additional QNASL® (beclomethasone dipropionate) Nasal Aerosol Data to be Presented at Annual Allergy Meeting Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Feb 13 Teva Announces FDA Approval of Generic Adderall XR® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
11 Feb 13 Teva Pharmaceuticals Announces Appointment of Dr. Arie Belldegrun to Board of Directors Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Feb 13 Teva Reports Fourth Quarter and Full Year 2012 Results Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 Feb 13 Teva Announces First Patient Enrolled in Largest Clinical Study to Date Evaluating AZILECT® for Mild Cognitive Impairment in Parkinson's Disease Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
31 Jan 13 Teva Announces Termination of Agreements with CureTech Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
23 Jan 13 Teva Reports Top-Line Results from Second Phase III Study of Armodafinil (NUVIGIL®) in Patients with Major Depression Associated with Bipolar 1 Disorder Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
22 Jan 13 Teva to Report Fourth Quarter and Full Year 2012 Financial Results on February 7, 2013 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Jan 13 Teva to Present at the 31st Annual J.P. Morgan Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
Advertising